Humacyte (HUMA) Short term Debt (2020 - 2025)

Humacyte (HUMA) has 6 years of Short term Debt data on file, last reported at $3.1 million in Q3 2025.

• Short term Debt for Q3 2025 came in at $3.1 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $3.1 million (changed N/A YoY), and the FY2024 annual result was $885000.0, changed N/A from the prior year.
• Short term Debt grew to $3.1 million in Q3 2025 per HUMA's latest filing, from $2.1 million in the prior quarter.
• Over five years, Short term Debt peaked at $12.9 million in Q1 2023 and troughed at $10000.0 in Q1 2021.
• A 5-year average of $4.2 million and a median of $3.1 million in 2025 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2021 and 2022: Short term Debt soared 89632.35% in 2021, then advanced 10.21% in 2022.
• A 5-year view of Short term Debt shows it stood at $3.9 million in 2021, then soared by 120.39% to $8.6 million in 2022, then jumped by 50.01% to $12.9 million in 2023, then slumped by 93.12% to $885000.0 in 2024, then surged by 247.12% to $3.1 million in 2025.
• Business Quant data shows HUMA's Short term Debt at $3.1 million in Q3 2025, $2.1 million in Q2 2025, and $1.7 million in Q1 2025.